canakinumab

Ligand id: 6773

Name: canakinumab

References
1. Church LD, McDermott MF. (2009)
Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders.
Curr. Opin. Mol. Ther.11 (1): 81-9. [PMID:19169963]
2. Gram H, Di Padova FE. (2008)
Antibodies to human IL-1β.
Patent number: US7446175. Assignee: Novartis Ag. Priority date: 22/08/2000. Publication date: 04/11/2008.
3. Ridker PM, Lüscher TF. (2014)
Anti-inflammatory therapies for cardiovascular disease.
Eur. Heart J.35 (27): 1782-91. [PMID:24864079]